ClinicalTrials.Veeva

Menu

The Relationship Between Serum PSA Levels and WBC, Delta Neutrophil Index (DNI) and Other Hematological Parameters

H

Hisar Intercontinental Hospital

Status

Completed

Conditions

Prostate Disease
Prostate Infection
Prostate Cancer

Treatments

Diagnostic Test: Serum PSA,Delta Neutrophil Index(DNI),WBC

Study type

Observational

Funder types

Other

Identifiers

NCT05399940
22/5-27

Details and patient eligibility

About

Purpose:

To find the correlation between hemogram parameters and Delta Neutrophil Index(DNI) and Serum PSA in patients presenting with the diagnosis of acute prostatitis.

Material-Metod: Serum PSA levels and hemogram parameters of patients who came to the urology outpatient clinic in January 2018 and May 2022 and were diagnosed with prostatitis were collected retrospectively.

Full description

Serum PSA levels and hemogram parameters of patients who came to the urology outpatient clinic in January 2018 and May 2022 and were diagnosed with prostatitis were collected retrospectively.

WBC, neutrophil, lymphocyte, neutrophil-lymphocyte ratio, delta neutrophil index (DNI), PLT, RDW, and MPV values were determined in the Hemogram Parameters. Serum Total PSA and Free PSA values of the patients were also checked. Urine culture, urinary ultrasound, and antibiotic therapy

Enrollment

250 patients

Sex

Male

Ages

18 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Acute prostatitis Male

Exclusion criteria

Prostate cancer Chronic prostatitis Other Urinary infections,

Trial design

250 participants in 2 patient groups

Group 1
Description:
:PSA\<4 ng/mL
Treatment:
Diagnostic Test: Serum PSA,Delta Neutrophil Index(DNI),WBC
Group 2
Description:
PSA\>4 ng/mL
Treatment:
Diagnostic Test: Serum PSA,Delta Neutrophil Index(DNI),WBC

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems